Loading...
01/10 16:01
Loading...
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Despite revenue growth and strategic expansion plans, the company faces significant challenges: declining gross profit, increased operating expenses, and a widening net loss. The cash position has deteriorated, raising liquidity concerns. While there are positive strategic initiatives, such as the NaturalShrimp facility and retailer partnerships, the lack of detailed guidance and the negative financial metrics overshadow these efforts. The Q&A session highlighted management's vague responses, further contributing to uncertainty. Given these factors, the stock price is likely to experience a negative reaction in the short term.
Revenue $2.8 million, a 9% increase year-over-year from $2.6 million in Q3 2024. This growth was driven by strong performance across the shelf-stable product portfolio, including Kick's, Sports Nutrition, Vitamin Whey, Pulp, and Pickle Party, which grew 54% year-over-year.
Core Herb Portfolio Hydro basil revenue increased by 21% year-over-year, and wheat grass revenue increased by 59% year-over-year. This reflects strength in the core herb portfolio.
Gross Profit $0.3 million, a decrease from $0.7 million in the prior year quarter. The decline was due to higher labor, freight, and raw material costs, as well as inflationary pressures within the nutraceutical supply chain.
Selling, General, and Administrative Expenses $3.8 million, an increase from $2.2 million in the same period last year. The increase was primarily due to expenses related to the assets purchased from NaturalShrimp and associated depreciation, legal, audit, and accounting expenses.
Net Loss $4 million, compared to a net loss of $2.1 million in Q3 2024. This reflects higher operating expenses and inflationary pressures.
Cash and Equivalents $0.8 million at the end of the quarter, compared to $3.5 million at year-end 2024. The decrease reflects operational cash outflows and strategic investments.
Shelf-stable product portfolio: Achieved 54% year-over-year growth in Q3, driven by brands like Kick, Sports Nutrition, Vitamin Whey, Pulp, and Pickle Party.
New product launches: Introduced USDA Organic fresh herb line at Kroger and Edible Garden branded herbs at The Fresh Market.
Functional food and beverage market: Positioned to capture share in a market projected to grow from $400 billion to $610 billion globally by 2030.
Retail footprint expansion: Expanded presence in Kroger, The Fresh Market, Pete's Fresh Market, Angelo Caputo’s Fresh Markets, PriceSmart, and Amazon.
International expansion: Strengthened global reach through partnerships with PriceSmart and Amazon.
Operational realignment: Benefited from the NaturalShrimp asset acquisition, enhancing efficiency and scalability.
Debt refinancing: Secured lower interest rates and favorable terms, reducing annual interest expenses and improving financial flexibility.
Strategic evolution: Shifted towards a CEA-informed consumer packaged goods (CPG) model, focusing on nonperishable product expansion and higher-value branded portfolio.
Sustainability and innovation: Pursuing new categories like nutraceuticals, sustainable proteins, and functional foods, guided by a zero-waste approach.
Gross Profit Decline: Gross profit decreased from $0.7 million in the prior year quarter to $0.3 million, driven by higher labor, freight, and raw material costs, as well as inflationary pressures within the nutraceutical supply chain.
Increased Operating Expenses: Selling, general, and administrative expenses rose to $3.8 million from $2.2 million in the same period last year, primarily due to expenses related to the NaturalShrimp asset acquisition and associated legal, audit, and accounting costs.
Net Loss Expansion: Net loss widened to $4 million compared to $2.1 million in the third quarter of 2024, reflecting increased costs and operational challenges.
Cash Position Decline: Cash and equivalents dropped to $0.8 million from $3.5 million at year-end 2024, raising concerns about liquidity and financial flexibility.
Inflationary Pressures: Inflationary pressures within the nutraceutical supply chain are impacting costs and profitability.
Debt Refinancing Risks: While the company refinanced its debt to secure lower interest rates and better terms, this indicates reliance on external financing and potential vulnerability to future interest rate changes or credit market conditions.
Revenue Growth: The company expects continued growth driven by disciplined execution, expanding retail partnerships, and advancing product innovation. The focus on high-margin, scalable CPG products is anticipated to capture meaningful market share in the clean-labeled CPG market.
Market Trends: The global functional food and beverage market is projected to grow from approximately $400 billion to $610 billion by 2030. In the U.S., sales of natural, organic, and functional products are expected to reach $386 billion by 2028, creating a favorable environment for the company's product portfolio.
Product Expansion: The company plans to pursue new categories, including nutraceuticals, sustainable proteins, and functional foods, aligning with its commitment to health, flavor, and environmental responsibility.
Operational Efficiency: Operational improvements are expected to enhance efficiency and scalability, supporting long-term growth.
Debt Refinancing: The company has refinanced its outstanding debt, securing a lower interest rate and more favorable terms, which is expected to reduce annual interest expenses and provide greater financial flexibility for strategic initiatives.
The selected topic was not discussed during the call.
Despite revenue growth and strategic expansion plans, the company faces significant challenges: declining gross profit, increased operating expenses, and a widening net loss. The cash position has deteriorated, raising liquidity concerns. While there are positive strategic initiatives, such as the NaturalShrimp facility and retailer partnerships, the lack of detailed guidance and the negative financial metrics overshadow these efforts. The Q&A session highlighted management's vague responses, further contributing to uncertainty. Given these factors, the stock price is likely to experience a negative reaction in the short term.
The earnings call presents a mixed picture: while there are strategic realignments and positive developments like the NaturalShrimp acquisition and high-margin product focus, financials reflect declining revenue and increased losses. The Q&A reveals growth in private labels and optimism about new product lines, but management's vague responses on specifics raise concerns. The company's dependency on new revenue streams and margin pressures add uncertainty. Considering these factors, the stock price is likely to remain stable, hence a neutral sentiment.
The earnings call presents a mixed outlook: while there are improvements in gross margin and a focus on higher-margin products, revenue decline and competitive pressures remain concerns. The Q&A highlights potential growth in new product lines and strategic acquisitions, but lacks clarity on financial impacts. The absence of shareholder return plans and the risks associated with acquisitions and regulatory compliance temper optimism. Overall, the sentiment is balanced, suggesting a neutral stock price movement.
The earnings call reflects mixed signals. The strategic refocus on high-margin products and improved gross margin are positives, while the revenue decline and competitive pressures are negatives. The acquisition of Natural Shrimp poses risks, and the lack of a share repurchase plan is neutral. Q&A insights show optimism in sports nutrition but uncertainty in shrimp operations. The overall sentiment is neutral, with potential for growth balanced by current challenges and uncertainties.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
